ICD-10-CM Billable Code

C44.311

Basal cell carcinoma of skin of nose

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) of the skin is the most common type of skin cancer. When it appears on the nose, it specifically affects the skin tissue in this prominent facial feature. Classified under ICD-10 code C44.311, this condition typically develops slowly and rarely spreads to other parts of the body. Early detection and treatment are vital to maintaining skin health and preventing extensive tissue damage.

Causes & Symptoms

Clinical Causes: Prolonged and cumulative exposure to ultraviolet (UV) radiation from the sun or tanning beds. Fair skin, light hair, and light eye color which offer less natural protection against UV damage. A history of skin cancer or previous skin injuries in the affected area. Inherited genetic factors that increase susceptibility to skin cancers. Compromised immune system, possibly due to immunosuppressive medications or medical conditions. Age, as the risk increases with advancing age due to cumulative sun exposure over time.

Key Symptoms: A shiny, pearly bump that may be translucent or pink in color. A flat, firm, and scaly lesion with a depressed center and rolled edges. Presence of ulcerations or sore that oozes, bleeds, and does not heal over time. Asymmetrical appearance or irregular borders on the affected skin area. Possible crusting or a scar-like appearance on the nose.

Diagnostic & Treatment

Diagnosis Path: Diagnosis generally involves a physical examination of the skin, focusing on the lesion's appearance, size, and texture. A dermatologist may perform a skin biopsy, removing a small sample of tissue from the lesion for microscopic analysis, which confirms the presence of basal cell carcinoma. In some cases, imaging studies may be ordered to assess the extent of tissue invasion, especially if the lesion is large or has penetrated deeper layers of skin.

Treatment Protocols: Surgical excision, where the lesion and some surrounding healthy tissue are removed to ensure complete removal. Mohs micrographic surgery, a precise technique that removes the cancer layer by layer while conserving as much healthy tissue as possible. Curettage and electrodessication, often used for small lesions, which involve scraping off the tumor and using electric current to destroy remaining cancer cells. Topical treatments, such as creams containing imiquimod or 5-fluorouracil, suitable for superficial lesions. Radiation therapy, used in cases where surgery isn't feasible or as adjunct treatment. Laser therapy, which may be employed in some cases to precisely target cancer cells.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.311 a billable ICD-10 code?
Yes, C44.311 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.311?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of nose and any associated comorbidities for accurate reporting.

Cite this Clinical Reference